Naval Medical Research Center: Research and Development of Protective Vaccines and Other Countermeasures Against Infectious Disease Agents of Military Importance
Closed Posted
- Opportunity number
- N62645-PA-17-1
- Agency
-
Department of Defense
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Science and Technology and other Research and Development
- Eligible applicants
-
- Unrestricted
Opportunity details come from Grants.gov. Updated .
Synopsis
2 versions
Update #2 · Latest ·
Please note that NMLC established a cutoff date and time for questions of 10 July 2017 at 3:00 PM Local Time. NMLC is answering questions as fast as possible and the first set of Questions and Answers has been posted as an attachment under "Related Documents". This sheet will be continuously updated, so please check the attachment frequently. The intent of this award is to fund an organization that can provide collaborative assistance with manpower (scientists, research associates, research assistants, laboratory aides , nurses, clinical trials staff, program managers, and technicians), materiel (research supplies, equipment), and clinical trials (research subject compensation) for research efforts focusing on the development and evaluation of preventive and therapeutic countermeasures for P. falciparum and P. vivax malaria, bacterial causes of infectious diarrhea, rickettsial pathogens, emerging viral pathogens including dengue, MERS-CoV, Chikungunya, Zika, novel flu viruses and multi-drug resistant bacteria. The award will be issued as a cooperative agreement between the recipient and the Government (the Infectious Diseases Directorate, Naval Medical Research Center [IDD-NMRC]). The award recipient (awardee) will collaborate with IDD-NMRC to develop and implement scientific research efforts and share substantial programmatic involvement with IDD-NMRC.
Update #1 ·
The intent of this award is to fund an organization that can provide collaborative assistance with manpower (scientists, research associates, research assistants, laboratory aides , nurses, clinical trials staff, program managers, and technicians), materiel (research supplies, equipment), and clinical trials (research subject compensation) for research efforts focusing on the development and evaluation of preventive and therapeutic countermeasures for P. falciparum and P. vivax malaria, bacterial causes of infectious diarrhea, rickettsial pathogens, emerging viral pathogens including dengue, MERS-CoV, Chikungunya, Zika, novel flu viruses and multi-drug resistant bacteria. The award will be issued as a cooperative agreement between the recipient and the Government (the Infectious Diseases Directorate, Naval Medical Research Center [IDD-NMRC]). The award recipient (awardee) will collaborate with IDD-NMRC to develop and implement scientific research efforts and share substantial programmatic involvement with IDD-NMRC.
Files
| File | Type | Posted |
|---|---|---|
| Questions and Answers 10 July 2017.docx | DOCX document | |
| Questions and Answers 03 July 2017.docx | DOCX document | |
| N62645-PA-17-1 Application Instructions.doc | DOC document | |
| N62645-PA-17-1 Program Announcement.docx | DOCX document | |
| oppN62645-PA-17-1-cfda12.340-instructions.doc | DOC document | |
| N62645-PA-17-1 Program Announcement.docx | DOCX document | |
| oppN62645-PA-17-1-cfda12.340.pdf | ||
| N62645-PA-17-1 Application Instructions.doc | DOC document |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity